Pseudomonas aeruginosa as an opportunistic pathogen produces several virulence factors. The most important of these factors are exotoxin A and type III secretion system (T3SS). The aim of this study was to determine the frequency of toxA, exoU and exoS genes among clinical isolates of P. aeruginosa. In this cross-sectional study from September 2011 to February 2012, 156 P. aeruginosa isolates were recovered from different clinical samples. Susceptibility testing against 10 antibiotics was performed on individual isolates by the disc diffusion method according to CLSI guidelines. Extracted DNA was subjected to PCR assay for determining the presence of toxA, exoU and exoS genes. Overall, the frequency of toxA, exoU and exoS genes were 90.4%, 66.7% and 65.4%, respectively. All of the abdominal and eye isolates were exoS + . 
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Materials and methods

Study design and clinical specimens
In this cross-sectional study, a total 156 P.
aeruginosa clinical isolates were obtained from 
Bacterial identification
All the isolates were identified as P.
aeruginosa using both the conventional microbiologic (e.g., Gram staining, capacity for growth at 42 °C, oxidase, and IMViC tests) methods and
aeruginosa isolates were stored in tryptic soy broth (TSB) (Merck Co., Germany) containing 20% glycerol at -70 °C until further study.
Antibiotic susceptibility testing
The antimicrobial susceptibility test was done by disk diffusion method on Muller-Hinton agar (Merck Co., Germany (4) 1 (25) 3 (29) 7 (24) 7 (24) 6 (21) 5 (17) 4 (14) 
Results
Of the total 156 P. aeruginosa isolates, majority of isolates were recovered from urine (n= 57) and sputum (n= 35) specimens ( 
Discussion
As detection of virulence genes in clinical isolates of P. aeruginosa is important (3, 18) , thus, in the present study, the frequency of some P.
aeruginosa virulence genes among different clinical isolates was characterized. As among T3SS, exoT and pcrV (part of the injection apparatus of the T3SS) genes exist in nearly all P. aeruginosa isolates from both clinical and environmental origins (3, 12, 19) , the presence of these genes was not evaluated in this study.
In our investigation, 100% of P. aeruginosa In a research in Poland by Wolska et al., the prevalence of toxA among the 62 clinical isolates of P. aeruginosa was 88.7%, which is comparable with our study. However, the frequency of exoS was more than that of the present study (75.8% vs.
66.7%) (17) . It seems that the exoU had been acquired through a mobile element (plasmid) integrated into the chromosome of P. aeruginosa.
Therefore, the lower prevalence of the gene than the other virulence genes could be due to this phenomenon (11) . However, in our analysis, this rate was nearly the same as exoS prevalence (65.4%
vs. 66.7%). In the study conducted by Mitove et al.
(20) on 202 cystic fibrosis (CF) and non-CF patients, the frequency of exoS was 62.4%, whereas the prevalence of exoU was found to be 30.2%, which is not in agreement with our study.
Interestingly, in a survey in France, the prevalence of exoS was markedly higher than other studies (94% in CF isolates vs. 80% in non-CF isolates) (24, 25) .
One of the limitations of this study was the small sample size of specimens such as blood, CSF, which could affect the results. However, beside the limitations, the current study has some outcomes.
First we showed a relatively high frequency of toxA, exoS and exoU genes among P. aeruginosa clinical isolates obtained in our area and this frequency was associated to high antibiotic resistance among the isolates. Second, it seems that the source of bacterial isolation is associated with the trend of acquisition of specific virulence genes and these genes may serve to cause specific infections. These results indicate the potential risk of these isolates in nosocomial infections which merit more attention. Of course, further studies are required with larger sample size and from other regions of country to reach a comprehensive conclusion.
